A Randomized, Multi-Center Trial to Evaluate the Safety & Immunogenicity of Staphylococcus Aureus Toxoids, rAT and rLukS-PV, in Healthy Volunteers.

Trial Profile

A Randomized, Multi-Center Trial to Evaluate the Safety & Immunogenicity of Staphylococcus Aureus Toxoids, rAT and rLukS-PV, in Healthy Volunteers.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Jun 2012

At a glance

  • Drugs Alum; Staphylococcus aureus vaccine
  • Indications Staphylococcal infections
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 27 Apr 2011 Status changed from recruiting to completed.
    • 10 Aug 2010 Nabi Pharmaceuticals is conducting this trial under contract to GlaxoSmithKline.
    • 10 Nov 2009 Status changed from planning to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top